Abstract
The present invention provides a dendritic cell for sieving a medicine for anti-C-type hepatitis virus infection, which particularly uses a Sip-L-expressing cell for continuously infecting and propagating C-type hepatitis virus and generating an adapted mutant virus. Using such an adapted mutant HCV virus as an infection source, the Sip-L expressing cells can be used for novel anti-HCV drug screening.
| Translated title of the contribution | Dendritic cell for sieving medicine for anti-C-type hepatitis virus infection |
|---|---|
| Original language | Chinese (Traditional) |
| IPC | C12N 5/10(2006.01); C12N 15/869(2006.01); C12N 15/12(2006.01) |
| State | Published - 16 11 2004 |
Bibliographical note
公開公告號: 2.00424312E8Announcement ID: 2.00424312E8
